How does Foundayo compare to other GLP-1s
Under these conditions, the increased secretion of counterregulatory hormones stimulates FFAs oxidation in the liver and accelerates the production of ketone bodies, which are metabolized in muscle, adipose tissue and, most importantly, in heart and brain ( As demonstrated in a recent meta-analysis, SGLT-2i treatment is associated with increased plasma fasting glucagon levels in patients with diabetes compared with non-SGLT-2i treatments with a reduction of insulin and increased ketone body levels ( via GH upregulation
5-Amino-1MQ (5-Amino-1-methylquinolinium) is a novel small molecule peptide classified as an NNMT inhibitor meaning it blocks the activity of the enzyme nicotinamide N-methyltransferase (NNMT), which plays a key role in cellular energy metabolism , fat storage , and aging
"There is limited evidence on the risk for GERD among patients with obesity who do not have type 2 diabetes," researchers wrote
However, it can cause irritation if used incorrectly
However, these drugs are known to cause a plethora of adverse effects such as weight gain, edema, intestinal discomfort and hypoglycemia (2)